MXD3 and neuroblastoma: Nanocomplexes made of superparamagnetic iron oxide NPs and an antisense oligonucleotide targeting the transcription regulator MAX dimerization protein 3 (MXD3, highly expressed in high-risk neuroblastoma) were developed to improve neuroblastoma treatment.